Application of calibration masks to TV vidicon tube

Photographic application method devised for overlaying test pattern masks on TV camera vidicon tubes prints the mask within 0.0076 cm of the vertical and horizontal center lines of the tube face. Entire process, including mask fabrication and alignment procedure, requires less than 10 minutes

Spin Dynamics of the Magnetoresistive Pyrochlore Tl_2Mn_2O_7

Neutron scattering has been used to study the magnetic order and spin dynamics of the colossal magnetoresistive pyrochlore Tl_2Mn_2O_7. On cooling from the paramagnetic state, magnetic correlations develop and appear to diverge at T_C (123 K). In the ferromagnetic phase well defined spin waves are observed, with a gapless ($\Delta <0.04$ meV) dispersion relation E=Dq^{2} as expected for an ideal isotropic ferromagnet. As T approaches T_C from low T, the spin waves renormalize, but no significant central diffusive component to the fluctuation spectrum is observed in stark contrast to the La$_{1-x}$(Ca,Ba,Sr)$_x$MnO$_3$ system. These results argue strongly that the mechanism responsible for the magnetoresistive effect has a different origin in these two classes of materials.Comment: 4 pages (RevTex), 4 figures (encapsulated postscript), to be published in Phys. Rev. Let

Spin Excitation Spectrum of La1−xAx_{1-x}A_xMnO3_3

As an effective model to describe perovskite-type manganates (La,$A$)MnO$_3$, the double-exchange model on a cubic lattice is investigated. Spin excitation spectrum of the model in the ground state is studied using the spin wave approximation. Spin wave dispersion relation observed in the inelastic neutron scattering experiment of La$_{0.7}$Pb$_{0.3}$MnO$_3$ is reproduced. Effective values for the electron bandwidth as well as Hund's coupling is estimated from the data.Comment: 10 pages LaTeX including 4 PS figure

Metabolic consequences of ileal interruption of the enterohepatic circulation of bile acids

The enterohepatic circulation of bile acids comprises a tightly regulated process of hepatic bile acid secretion, intestinal reabsorption and transport back to the liver. Disruption of this process has significant consequences for both gastrointestinal, liver and whole-body homeostasis and therefore offers opportunities for therapeutic intervention. In this review we discuss the effects of (pharmacological) interruption of the enterohepatic circulation at different levels. Recently, several studies have been published on ileal interruption of the enterohepatic circulation of bile acids, targeting the apical-sodium dependent bile acid transporter (ASBT, SLC10A2), as therapy for various diseases. However, ambiguous results have been reported and in-depth mechanistic insights are lacking. Here we discuss these novel studies and review the current knowledge and literature on the consequences of ASBT inhibition and its potential effects on physiology and metabolism

Editorial:FGF21 as a therapeutic target for obesity and insulin resistance: from rodent models to humans

Obesity is a global pandemic that requires the urgent development of therapies and prevention strategies. To define new pharmacologic therapies or nutritional approaches it is mandatory to find new targets. Fibroblast growth factor 21 (FGF21) is considered a potential target to treat obesity, due to its favorable metabolic activity, signalling pathways and regulatory mechanisms. It is well-documented that FGF21 is induced by a wide range of biological stress conditions and a key signal that communicates and coordinates the physiologic response to restore the metabolic homeostasis in different tissues (1). FGF21 is elevated in pathological conditions such as obesity, insulin resistance, or fatty liver disease where an impairment of its signalling has been described (2). On the other hand, FGF21 analogues tested in overweight/obese patients with type 2 diabetes or NAFLD/NASH can reduce dyslipidaemia and steatosis, but improvements in glycaemic control or body weight were not globally restored (3). This suggests that pharmacologic effects of FGF21 are different from its physiological effects. In this Research Topic “FGF21 as a therapeutic target for obesity and insulin resistance: from rodent models to humans”, we include publications related to new advances involving FGF21, its signalling pathway, and its potential as a target to treat obesityinfo:eu-repo/semantics/publishedVersio